Celldex Therapeutics, Inc.

Historical 13F Holders

Symbol
CLDX
CUSIP
15117B202
All holders as of
Q1 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 239 73.0 M $2.31 B
2025 Q4 193 73.3 M $1.99 B
2025 Q3 198 70.9 M $1.83 B
2025 Q2 194 73.4 M $1.49 B
2025 Q1 184 73.6 M $1.34 B
2024 Q4 195 73.7 M $1.86 B
2024 Q3 206 71.9 M $2.44 B
2024 Q2 196 70.0 M $2.59 B
2024 Q1 211 70.1 M $2.94 B
2023 Q4 187 62.3 M $2.47 B
2023 Q3 163 50.6 M $1.39 B
2023 Q2 165 50.2 M $1.70 B
2023 Q1 179 49.5 M $1.78 B
2022 Q4 191 51.0 M $2.27 B
2022 Q3 177 49.5 M $1.39 B
2022 Q2 193 48.3 M $1.30 B
2022 Q1 194 49.9 M $1.70 B
2021 Q4 206 46.8 M $1.81 B
2021 Q3 182 43.3 M $2.33 B
2021 Q2 148 36.6 M $1.23 B
2021 Q1 129 34.5 M $710 M
2020 Q4 145 37.4 M $656 M
2020 Q3 102 32.2 M $477 M
2020 Q2 89 27.8 M $361 M
2020 Q1 52 3.97 M $6.59 M
2019 Q4 54 4.01 M $8.94 M
2019 Q3 62 3.71 M $7.90 M
2019 Q2 64 3.47 M $9.29 M
2019 Q1 60 2.60 M $12.8 M
2018 Q4 1 100 k $20.0 k